Rodman & Renshaw Starts CorMedix (CRMD) at Buy
Tweet
Share
E-mailGet Alerts CRMD Hot Sheet
Price: $8.52 --0%
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
Rodman & Renshaw analyst Brandon Folkes initiates coverage on CorMedix (NASDAQ: CRMD) with a Buy rating and a price target of $13.00.
For an analyst ratings summary and ratings history on CorMedix click here. For more ratings news on CorMedix click here.
Shares of CorMedix closed at $5.65 yesterday.
You May Also Be Interested In
- Deutsche Bank Starts Ardagh Metal Packaging S.A. (AMBP) at Hold
- Piper Sandler Starts Sphere Entertainment (SPHR) at Overweight
- H.C. Wainwright Reiterates Buy Rating on CorMedix (CRMD)
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
